Telocinobufagin (Telobufotoxin)
(Synonyms: 远华蟾蜍精,Telobufotoxin; Telocinobufogenin) 目录号 : GC33530A cardiotonic steroid with diverse biological activities
Cas No.:472-26-4
Sample solution is provided at 25 µL, 10mM.
Telocinobufagin is a cardiotonic steroid that has been found in skin secretions of the toad B. rubescens and has diverse biological activities.1,2,3,4 It inhibits human kidney Na+/K+-ATPase with an IC50 value of 44.2 nM.3 Telocinobufagin (9.9 μg/ml) increases contraction force in isolated frog ventricle strips by 30.2%.2 It is cytotoxic to HL-60, HCT8, SF295, MDA-MB-435 cancer cells and human peripheral blood lymphocytes (IC50s = 0.06, 0.06, 0.03, 0.11, and 0.05 μM, respectively).4 Telocinobufagin is also active against E. coli and S. aureus (MICs = 64 and 128 μg/ml, respectively).2
1.Pavlovic, D.The role of cardiotonic steroids in the pathogenesis of cardiomyopathy in chronic kidney diseaseNephron Clin. Pract.128(1-2)11-21(2014) 2.Cunha Filho, G.A., Schwartz, C.A., Resck, I.S., et al.Antimicrobial activity of the bufadienolides marinobufagin and telocinobufagin isolated as major components from skin secretion of the toad Bufo rubescensToxicon.45(6)777-782(2005) 3.Touza, N.A., P??as, E.S., Quintas, L.E.M., et al.Inhibitory effect of combinations of digoxin and endogenous cardiotonic steroids on Na+/K+-ATPase activity in human kidney membrane preparationLife Sci.88(1-2)39-42(2011) 4.G.A., C.-F., Resck, I.S., Cavalcanti, B.C., et al.Cytotoxic profile of natural and some modified bufadienolides from toad Rhinella schneideri parotoid gland secretionToxicon.56(3)339-348(2010)
Cas No. | 472-26-4 | SDF | |
别名 | 远华蟾蜍精,Telobufotoxin; Telocinobufogenin | ||
Canonical SMILES | O[C@@]([C@@]1(CC2)C)(CC[C@@H]1C(C=C3)=COC3=O)[C@@](CC[C@@]45O)([H])[C@@]2([H])[C@]4(CC[C@H](O)C5)C | ||
分子式 | C24H34O5 | 分子量 | 402.52 |
溶解度 | DMSO : 50 mg/mL (124.22 mM; Need ultrasonic) | 储存条件 | Store at -20°C |
General tips | 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。 为了提高溶解度,请将管子加热至37℃,然后在超声波浴中震荡一段时间。 |
||
Shipping Condition | 评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备RT,或根据请求配备蓝冰。 |
制备储备液 | |||
1 mg | 5 mg | 10 mg | |
1 mM | 2.4843 mL | 12.4217 mL | 24.8435 mL |
5 mM | 0.4969 mL | 2.4843 mL | 4.9687 mL |
10 mM | 0.2484 mL | 1.2422 mL | 2.4843 mL |
第一步:请输入基本实验信息(考虑到实验过程中的损耗,建议多配一只动物的药量) | ||||||||||
给药剂量 | mg/kg | 动物平均体重 | g | 每只动物给药体积 | ul | 动物数量 | 只 | |||
第二步:请输入动物体内配方组成(配方适用于不溶于水的药物;不同批次药物配方比例不同,请联系GLPBIO为您提供正确的澄清溶液配方) | ||||||||||
% DMSO % % Tween 80 % saline | ||||||||||
计算重置 |
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL saline,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
3. 以上所有助溶剂都可在 GlpBio 网站选购。
Quality Control & SDS
- View current batch:
- Purity: >99.50%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet